Tuesday, December 31, 2019

Indoco gets USFDA nod for Febuxostat tablets

Indoco gets USFDA nod for Febuxostat tablets "Indoco Remedies received final approval of its ANDA (Abbreviated New Drug Application) for Febuxostat tablets 40 mg and 80 mg, which is therapeutically equivalent to the Reference Listed Drug (RLD), viz, Uloric Tablets 40 mg and 80 mg of Takeda Pharmaceuticals USA, Inc," the company said in a filing to the BSE.

from Moneycontrol Business News https://ift.tt/2tmoKe3

No comments:

Post a Comment

Tariffs a temporary storm, structural reforms key for India: Arvind Sanger

Arvind Sanger of Geosphere Capital Management suggests a trade deal with the U.S. would benefit India by reducing market uncertainty and pro...